Not checked for notices yet.
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial
Sara Lonardi, Valter Torri, Fortunato Ciardiello and 22 more
ESMO Open · 2020
doi:10.1136/esmoopen-2020-000911
Cited by papers we hold 3
- The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors · 2024No notice
- Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer · 2023No notice
- HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer · 2022No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.